英华号周播报|巴菲特是怎么买医药股的？黄金还能继续涨吗？

Group 1 - The technology sector's trading congestion has returned to relatively low levels, indicating potential investment opportunities [2] - The precious metals market has seen a significant surge, with questions arising about the future performance of gold and silver [3] - A mid-term perspective suggests that the A-share market may continue to follow the main theme of Chinese manufacturing [3] Group 2 - The evolution of China's index-enhanced funds is highlighted, transitioning from niche to mainstream [5] - The consensus on "de-dollarization" raises questions about the future trajectory of gold [3] - Insights into Warren Buffett's investment strategies in the pharmaceutical sector are discussed [3] Group 3 - The year 2025 is projected to be a pivotal year for China's innovative drug industry, marking a year of revenue growth, profit leap, and valuation uplift, presenting systemic investment opportunities [17]